cyclohexanol has been researched along with hu 308 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gokoh, M; Kishimoto, S; Oka, S; Sugiura, T; Wakui, J | 1 |
| Fernández-Ruiz, J; García, C; García-Arencibia, M; Palomo-Garo, C; Pertwee, R; Ramos, J | 1 |
| Hind, WH; O'Sullivan, SE; Stanley, CP; Tufarelli, C | 1 |
3 other study(ies) available for cyclohexanol and hu 308
| Article | Year |
|---|---|
Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol.
Topics: Administration, Cutaneous; Animals; Arachidonic Acids; Benzoxazines; Calcium; Cannabinoid Receptor Agonists; Cannabinoids; Cell Movement; Cyclohexanols; Dose-Response Relationship, Drug; Ear, External; Endocannabinoids; Glycerides; HL-60 Cells; Humans; Inflammation; Intracellular Fluid; Leukocytes; Ligands; Male; Mice; Mice, Inbred ICR; Morpholines; Naphthalenes; Peroxidase; Tetradecanoylphorbol Acetate | 2006 |
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease.
Topics: Animals; Antioxidants; Cannabinoids; Cyclohexanols; Disease Models, Animal; Dopamine; Dronabinol; Glutamic Acid; Lipopolysaccharides; Male; Mice; Motor Activity; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Substantia Nigra; Tyrosine 3-Monooxygenase | 2011 |
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.
Topics: Adult; Aged; Aged, 80 and over; Aorta; Arachidonic Acids; Cannabinoids; Cyclohexanols; Endocannabinoids; Endothelial Cells; Endothelium, Vascular; Female; Humans; Intracellular Signaling Peptides and Proteins; Male; Mesenteric Arteries; Middle Aged; Nitric Oxide; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger; Vasodilation | 2016 |